Schwartz L - Search Results

1

Lymphohematopoietic cancer in styrene-butadiene polymerization workers.

Santos-Burgoa C, Matanoski GM, Zeger S, Schwartz L. Santos-Burgoa C, et al. Among authors: schwartz l. Am J Epidemiol. 1992 Oct 1;136(7):843-54. doi: 10.1093/aje/136.7.843. Am J Epidemiol. 1992. PMID: 1442750

2

Cancer epidemiology among styrene-butadiene rubber workers.

Matanoski G, Francis M, Correa-Villaseñor A, Elliott E, Santos-Burgoa C, Schwartz L. Matanoski G, et al. Among authors: schwartz l. IARC Sci Publ. 1993;(127):363-74. IARC Sci Publ. 1993. PMID: 8070882

3

Mortality of workers in styrene-butadiene polymer production.

Matanoski GM, Schwartz L. Matanoski GM, et al. Among authors: schwartz l. J Occup Med. 1987 Aug;29(8):675-80. J Occup Med. 1987. PMID: 3655951

4

Mortality of a cohort of workers in the styrene-butadiene polymer manufacturing industry (1943-1982).

Matanoski GM, Santos-Burgoa C, Schwartz L. Matanoski GM, et al. Among authors: schwartz l. Environ Health Perspect. 1990 Jun;86:107-17. doi: 10.1289/ehp.9086107. Environ Health Perspect. 1990. PMID: 2401250 Free PMC article.

5

Recognition Awards in Pathology Specialty Societies.

Wobker SE, Ginter PS, Parra-Herran C, Schwartz LE, Booth GS, Fitzhugh VA, Silver JK, Khani F. Wobker SE, et al. Among authors: schwartz le. Am J Clin Pathol. 2022 Aug 6:aqac076. doi: 10.1093/ajcp/aqac076. Online ahead of print. Am J Clin Pathol. 2022. PMID: 35932465

6

Novel biomarkers in NSCLC: Radiomic analysis, kinetic analysis, and circulating tumor DNA.

Maniar A, Wei AZ, Dercle L, Bien HH, Fojo T, Bates SE, Schwartz LH. Maniar A, et al. Among authors: schwartz lh. Semin Oncol. 2022 Jul 3:S0093-7754(22)00042-2. doi: 10.1053/j.seminoncol.2022.06.002. Online ahead of print. Semin Oncol. 2022. PMID: 35914982

7

APPLICATION OF THE LUGANO CLASSIFICATION FOR INITIAL EVALUATION, STAGING, AND RESPONSE ASSESSMENT OF HODGKIN AND NON-HODGKIN LYMPHOMA: THE PROLOG CONSENSUS INITIATIVE (PART 2- TECHNICAL).

Ricard F, Barrington S, Korn R, Brueggenwerth G, Trotman J, Cheson B, Salles G, Schwartz L, Goldmacher G, Jarecha R, Narang J, Broussais F, Galette P, Liu M, Bajpai S, Perlman E, Gillis J, Smalberg I, Terve P, Zahlmann G, Schmid A. Ricard F, et al. Among authors: schwartz l. J Nucl Med. 2022 Jul 14:jnumed.122.264124. doi: 10.2967/jnumed.122.264124. Online ahead of print. J Nucl Med. 2022. PMID: 35835581

8

APPLICATION OF THE LUGANO CLASSIFICATION FOR INITIAL EVALUATION, STAGING, AND RESPONSE ASSESSMENT OF HODGKIN AND NON-HODGKIN LYMPHOMA: THE PROLOG CONSENSUS INITIATIVE (PART 1- CLINICAL).

Ricard F, Cheson B, Barrington S, Trotman J, Schmid A, Brueggenwerth G, Salles G, Schwartz L, Goldmacher G, Jarecha R, Broussais F, Narang J, Galette P, Liu M, Bajpai S, Perlman E, Gillis J, Smalberg I, Terve P, Zahlmann G, Korn R. Ricard F, et al. Among authors: schwartz l. J Nucl Med. 2022 Jul 14:jnumed.122.264106. doi: 10.2967/jnumed.122.264106. Online ahead of print. J Nucl Med. 2022. PMID: 35835580

9

Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical Trial.

Katz MHG, Shi Q, Meyers J, Herman JM, Chuong M, Wolpin BM, Ahmad S, Marsh R, Schwartz L, Behr S, Frankel WL, Collisson E, Leenstra J, Williams TM, Vaccaro G, Venook A, Meyerhardt JA, O'Reilly EM. Katz MHG, et al. Among authors: schwartz l. JAMA Oncol. 2022 Jul 14:e222319. doi: 10.1001/jamaoncol.2022.2319. Online ahead of print. JAMA Oncol. 2022. PMID: 35834226

10

Time Cost and Demand: Implications for Public Policy.

Schwartz LP, Hursh SR. Schwartz LP, et al. Perspect Behav Sci. 2022 Jul 6:1-16. doi: 10.1007/s40614-022-00349-8. Online ahead of print. Perspect Behav Sci. 2022. PMID: 35812525 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results